Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Juillet

Showing results (21-30 of 63) with videos related to

Pageof 7
Sort By:
Therapie|August 1, 1988
[Responsibility of the pharmaceutical industry toward the first undesirable effects of new products]Y Juillet, F de Cremiers
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|January 1, 1996
[Transfer of drug industry technologies to developing countries]Y Juillet, O Amédée-Manesme
Soins; La Revue De Reference Infirmiere|March 5, 1978
[Treatment of trophic disorders in arterial diseases of the lower limbs]Y Juillet, M Le Goff
Therapie|March 1, 1981
[Clinical course of 103 patients with arteriosclerosis obliterans (author's transl)]Y Juillet, D Dehais, E Housset
Therapie|October 27, 2001
[Communication and transparency concerning risk-benefit analysis in public health: the example of medication]J P Lehner, F Meyer, Y Juillet
Coeur Et Medecine Interne|April 1, 1980
[Ilio-femoral vein thrombosis: a complication of right heart catheterization by a femoral vein approach: a series of 6 cases]Y Juillet, J N Fiessinger, E Housset
Therapie|November 9, 2002
[Compliance, efficacy and quality of life]J F Bergmann, E Dohin, Y Juillet, et al.
La Revue Du Praticien|June 1, 1977
[Cause and prevention of pulmonary embolism. Rehabilitation of deep venous thrombosis]J N Fiessinger, Y Juillet, E Housset
Bulletin De L'Academie Nationale De Medecine|July 20, 2022
[Perception of medication risk by the public and role of the media]G Bouvenot, P Le Coz, Y Juillet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 1976
[Course and prognostic factors of unstable angina. Apropos of 100 cases]Y Juillet, Y Grosgogeat, J Vedel, et al.
Pageof 7

Showing results (21-30 of 63) with videos related to

Sort By:
Pageof 7
Therapie|August 1, 1988
[Responsibility of the pharmaceutical industry toward the first undesirable effects of new products]Y Juillet, F de Cremiers
Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie|January 1, 1996
[Transfer of drug industry technologies to developing countries]Y Juillet, O Amédée-Manesme
Soins; La Revue De Reference Infirmiere|March 5, 1978
[Treatment of trophic disorders in arterial diseases of the lower limbs]Y Juillet, M Le Goff
Therapie|March 1, 1981
[Clinical course of 103 patients with arteriosclerosis obliterans (author's transl)]Y Juillet, D Dehais, E Housset
Therapie|October 27, 2001
[Communication and transparency concerning risk-benefit analysis in public health: the example of medication]J P Lehner, F Meyer, Y Juillet
Coeur Et Medecine Interne|April 1, 1980
[Ilio-femoral vein thrombosis: a complication of right heart catheterization by a femoral vein approach: a series of 6 cases]Y Juillet, J N Fiessinger, E Housset
Therapie|November 9, 2002
[Compliance, efficacy and quality of life]J F Bergmann, E Dohin, Y Juillet, et al.
La Revue Du Praticien|June 1, 1977
[Cause and prevention of pulmonary embolism. Rehabilitation of deep venous thrombosis]J N Fiessinger, Y Juillet, E Housset
Bulletin De L'Academie Nationale De Medecine|July 20, 2022
[Perception of medication risk by the public and role of the media]G Bouvenot, P Le Coz, Y Juillet, et al.
Archives Des Maladies Du Coeur Et Des Vaisseaux|December 1, 1976
[Course and prognostic factors of unstable angina. Apropos of 100 cases]Y Juillet, Y Grosgogeat, J Vedel, et al.
Pageof 7